Interleukin-27 and interleukin-12 augment activation of distinct cord blood natural killer cells responses via STAT3 pathways. 2012

Juei-Chang Chen, and Ai-Ju Huang, and Shih-Chang Chen, and Jia-Long Wu, and Wen-Mein Wu, and Han-Sun Chiang, and Chia-Hao Chan, and Chih-Ming Lin, and Yu-Tzu Huang
Department of Medical Research, Tao-Yuan General Hospital, Taoyuan, Taiwan.

OBJECTIVE Umbilical cord blood is rich in primitive natural killer (NK) cells, which are activated by interleukin (IL)-12. It was previously reported that a novel IL-12 family cytokine, IL-27 comprised of EBI3 and p28, was elevated in maternal serum during normal pregnancy. Thus, we compared the immune regulatory functions of IL-27 and IL-12 on mononuclear cells derived from cord blood and adult peripheral blood. METHODS After stimulation with IL-27, IL-12, and IL-27 combined with IL-12, the cytotoxicity against BJAB lymphoma cells by blood mononuclear cells was performed. Then immunofluorescence staining, reverse transcriptase-polymerase chain reaction and Western blotting were used to detect the effects of IL-27 and IL-12 in isolated NK cells. RESULTS IL-27, IL-12, and IL-27 combined with IL-12 enhanced the cytotoxicity of adult peripheral blood cells and cord blood cells, but the proliferation of distinct subpopulations of cells was not evident. Similar results were also obtained with purified cord blood NK cells. Interestingly, distinct from IL-12, IL-27 could induce aggregation and morphological changes of umbilical cord blood cells. Finally, IL-27 combined with IL-12 could stimulate increased IL-27 receptor (gp130 and WSX-1) transcripts in purified cord blood NK cells. However, the activation of signal transducer and activator of transcription 3 (STAT3) in NK cells was only detected in the presence of IL-27, but not IL-12 alone. CONCLUSIONS From previous results, we summarize our current understanding of the augmentation of distinct regulation of NK cells by IL-27 and IL-12.

UI MeSH Term Description Entries
D007378 Interleukins Soluble factors which stimulate growth-related activities of leukocytes as well as other cell types. They enhance cell proliferation and differentiation, DNA synthesis, secretion of other biologically active molecules and responses to immune and inflammatory stimuli. Interleukin
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D003601 Cytotoxicity Tests, Immunologic The demonstration of the cytotoxic effect on a target cell of a lymphocyte, a mediator released by a sensitized lymphocyte, an antibody, or complement. AHG-CDC Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Tests,Microcytotoxicity Tests,Anti Human Globulin Complement Dependent Cytotoxicity Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunologic,Cytotoxicity Tests, Anti-Human Globulin Complement-Dependent,Cytotoxicity Tests, Immunological,Immunologic Cytotoxicity Test,Immunologic Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin-Augmented,Lymphocytotoxicity Tests, Antiglobulin-Augmented,Microcytotoxicity Test,AHG CDC Tests,AHG-CDC Test,Anti Human Globulin Complement Dependent Cytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunological,Cytotoxicity Tests, Anti Human Globulin Complement Dependent,Immunological Cytotoxicity Test,Immunological Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin Augmented,Lymphocytotoxicity Tests, Antiglobulin Augmented
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D005312 Fetal Blood Blood of the fetus. Exchange of nutrients and waste between the fetal and maternal blood occurs via the PLACENTA. The cord blood is blood contained in the umbilical vessels (UMBILICAL CORD) at the time of delivery. Cord Blood,Umbilical Cord Blood,Blood, Cord,Blood, Fetal,Blood, Umbilical Cord,Bloods, Cord,Bloods, Fetal,Bloods, Umbilical Cord,Cord Blood, Umbilical,Cord Bloods,Cord Bloods, Umbilical,Fetal Bloods,Umbilical Cord Bloods
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015153 Blotting, Western Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes. Immunoblotting, Western,Western Blotting,Western Immunoblotting,Blot, Western,Immunoblot, Western,Western Blot,Western Immunoblot,Blots, Western,Blottings, Western,Immunoblots, Western,Immunoblottings, Western,Western Blots,Western Blottings,Western Immunoblots,Western Immunoblottings
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Juei-Chang Chen, and Ai-Ju Huang, and Shih-Chang Chen, and Jia-Long Wu, and Wen-Mein Wu, and Han-Sun Chiang, and Chia-Hao Chan, and Chih-Ming Lin, and Yu-Tzu Huang
January 1996, Pediatric research,
Juei-Chang Chen, and Ai-Ju Huang, and Shih-Chang Chen, and Jia-Long Wu, and Wen-Mein Wu, and Han-Sun Chiang, and Chia-Hao Chan, and Chih-Ming Lin, and Yu-Tzu Huang
November 1999, Cytokine,
Juei-Chang Chen, and Ai-Ju Huang, and Shih-Chang Chen, and Jia-Long Wu, and Wen-Mein Wu, and Han-Sun Chiang, and Chia-Hao Chan, and Chih-Ming Lin, and Yu-Tzu Huang
January 1995, Japanese journal of cancer research : Gann,
Juei-Chang Chen, and Ai-Ju Huang, and Shih-Chang Chen, and Jia-Long Wu, and Wen-Mein Wu, and Han-Sun Chiang, and Chia-Hao Chan, and Chih-Ming Lin, and Yu-Tzu Huang
June 1995, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research,
Juei-Chang Chen, and Ai-Ju Huang, and Shih-Chang Chen, and Jia-Long Wu, and Wen-Mein Wu, and Han-Sun Chiang, and Chia-Hao Chan, and Chih-Ming Lin, and Yu-Tzu Huang
August 1996, Blood,
Juei-Chang Chen, and Ai-Ju Huang, and Shih-Chang Chen, and Jia-Long Wu, and Wen-Mein Wu, and Han-Sun Chiang, and Chia-Hao Chan, and Chih-Ming Lin, and Yu-Tzu Huang
July 1989, The Journal of experimental medicine,
Juei-Chang Chen, and Ai-Ju Huang, and Shih-Chang Chen, and Jia-Long Wu, and Wen-Mein Wu, and Han-Sun Chiang, and Chia-Hao Chan, and Chih-Ming Lin, and Yu-Tzu Huang
January 2015, Cytotherapy,
Juei-Chang Chen, and Ai-Ju Huang, and Shih-Chang Chen, and Jia-Long Wu, and Wen-Mein Wu, and Han-Sun Chiang, and Chia-Hao Chan, and Chih-Ming Lin, and Yu-Tzu Huang
August 2008, Human immunology,
Juei-Chang Chen, and Ai-Ju Huang, and Shih-Chang Chen, and Jia-Long Wu, and Wen-Mein Wu, and Han-Sun Chiang, and Chia-Hao Chan, and Chih-Ming Lin, and Yu-Tzu Huang
July 1996, Nature,
Juei-Chang Chen, and Ai-Ju Huang, and Shih-Chang Chen, and Jia-Long Wu, and Wen-Mein Wu, and Han-Sun Chiang, and Chia-Hao Chan, and Chih-Ming Lin, and Yu-Tzu Huang
October 2000, Biology of the neonate,
Copied contents to your clipboard!